Neumora Therapeutics Balance Sheet (2022-2026) | NMRA

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 252.51M240.94M210.87M204.22M412.28M374.04M182.93M150.68M275.71M142.15M126.86M124.52M129.07M182.53M147.07M
Receivables - Other (Quarter) 0.92M0.67M0.94M0.91M1.63M
Prepaid Assets (Quarter) 11.90M16.17M24.30M20.07M26.68M6.09M5.26M4.30M5.32M5.56M8.01M6.36M
Current Assets (Quarter) 387.95M525.74M478.28M442.79M398.32M348.61M314.06M254.87M222.91M177.08M190.54M153.43M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 2.41M1.93M1.79M1.64M1.48M1.30M1.14M0.98M0.09M0.08M0.04M0.03M
Long-Term Investments (Quarter) 23.51M9.91M9.85M0.30M
Other Non-Current Assets (Quarter) 1.26M1.26M1.21M1.21M1.21M1.21M1.21M1.21M1.21M1.21M1.21M0.30M0.20M0.05M0.05M
Non-Current Assets (Quarter) 38.28M19.01M17.92M7.43M6.15M3.93M2.92M1.88M0.92M0.75M0.51M0.44M
Assets (Quarter) 426.23M544.75M496.19M450.21M404.47M352.54M316.97M256.75M223.82M177.83M191.05M153.88M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 7.15M2.23M0.34M1.49M1.08M6.11M3.31M1.05M0.64M0.55M3.38M5.06M
Payables (Quarter) 7.15M2.23M0.34M1.49M1.08M6.11M3.31M1.05M0.64M0.55M3.38M5.06M
Accumulated Expenses (Quarter) 8.40M23.35M21.26M4.66M18.30M22.76M9.97M6.16M6.64M24.98M11.49M4.82M
Other Accumulated Expenses (Quarter) 0.41M0.38M0.75M0.54M0.37M0.39M0.33M0.41M0.45M0.45M0.72M0.74M
Current Leases (Quarter) 3.37M3.40M3.38M3.49M3.61M2.75M1.85M0.94M0.17M0.26M0.28M0.29M
Total Current Liabilities (Quarter) 23.70M29.12M25.11M24.61M23.12M31.74M29.89M28.38M21.16M25.84M32.45M30.11M
Non-Current Liabilities
Non-Current Debt (Quarter) 19.45M19.56M54.53M52.96M
Preferred Stock Liabilities (Quarter) 817.10M843.69M843.69M843.69M
Operating Leases (Quarter) 5.07M2.75M1.85M0.94M0.34M0.27M0.19M0.12M
Other Non-Current Liabilities (Quarter) 0.63M0.19M0.15M0.12M0.09M0.06M0.02M
Total Non-Current Liabilities (Quarter) 28.77M31.87M26.96M25.55M23.12M31.74M29.89M40.95M45.67M
Total Liabilities (Quarter) 422.00M29.40M477.92M513.54M32.06M27.12M25.67M23.21M31.80M29.91M28.38M40.95M45.67M87.18M83.20M
Shareholder's Equity
Total Debt (Quarter) 19.45M19.56M54.53M52.96M
Common Equity (Quarter) -422.00M-446.85M-477.92M-513.54M512.69M469.08M424.54M381.26M320.74M287.06M228.36M182.88M132.16M103.87M70.68M
Shareholder's Equity (Quarter) -422.00M-446.85M-477.92M-513.54M512.69M469.08M424.54M381.26M320.74M287.06M228.36M182.88M132.16M103.87M70.68M
Liabilities and Shareholders Equity (Quarter) 426.23M544.75M496.19M450.21M404.47M352.54M316.97M256.75M223.82M177.83M191.05M153.88M
Retained Earnings (Quarter) -0.77M-0.31M-703.43M-757.15M-815.86M-888.40M-947.22M-1015.21M-1067.94M-1124.70M-1184.15M-1237.61M
Treasury Shares (Quarter) 2.90M0.35M0.84M1.51M1.56M0.41M1.44M1.11M0.10M0.66M0.66M0.06M
Shares Outstanding (Quarter) 32.59M32.61M32.71M32.82M152.70M158.83M159.36M159.95M160.48M161.71M161.75M161.95M161.95M4.50M182.16M